Man Group »

Rapt Therapeutics shares owned by Man Group

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Man Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $637k 19k 33.87

More positions owned by Man Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A (MA)
Costco Wholesale Corporation (COST)
Abbvie (ABBV)
Bristol Myers Squibb (BMY)

View all positions for Man Group

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics